New study probes Dupilumab's inner workings in asthma patients with obesity
NCT ID NCT05478824
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 27 times
Summary
This study looked at how the drug dupilumab changes gene and protein activity in airway cells from adults with allergic asthma and obesity (BMI 30 or higher). Researchers collected nasal cells from 28 participants to see how dupilumab affects inflammation signals. The goal was to understand why some people respond differently to treatment, not to test a cure or symptom relief directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke Asthma Allergy and Airway Center
Durham, North Carolina, 27208, United States
Conditions
Explore the condition pages connected to this study.